To further investigate whether Nrf2 is a key downstream mediator of ACOD1's protective effects in exacerbated ALI in the context of obesity, we utilized the Nrf2 inhibitor ML385 in both in vivo and in vitro experiments. Here, ACOD1 is linked to obesity disorder.